Asutralia : Pharmacovigilance obligations of medicine sponsors 21 October 2022 All news Australia-Pharmacovigilance-obligations-of-medicine-sponsors-_-17Oct2022-1Télécharger
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP)10-13 October 2022 17 October 2022 All news EU-Meeting-highlights-from-the-CHMP_10-13-October-2022-1Télécharger
EU : Q&A: Good clinical practice (GCP) 14 October 2022 All news EU-EMA-QA_-Good-clinical-practice-_-updated-Oct2022-2Télécharger
EU: Explanatory note on pharmacovigilance fees payable to the European Medicines Agency 10 October 2022 All news EU_explanatory-note-pharmacovigilance-fees-payable-ema-3-october-2022_en_03Oct2022-1Télécharger
France : Application for early access authorisation 7 October 2022 All news France-Demande-dautorisation-dacces-precoce-ANSM_06Oct2022-1Télécharger
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26-29 September 2022 3 October 2022 All news https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-26-29-september-2022
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 September 2022 30 September 2022 All news https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-12-15-september-2022
Update on the surveillance of vaccines and treatments against the Monkeypox virus 23 September 2022 All news https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-et-traitements-contre-le-virus-monkeypox
